
|Articles|December 1, 2003
Intraocular implant to be tested on first patients
Bethesda, MD- Ten patients with late-stage retinitis pigmentosa (RP) will be the first humans to receive intraocular, polymer implants containing genetically modified human retinal epithelial cells that researchers hope will prevent further vision loss.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
2
EyeCon 2026: ODs and MDs pull up a chair
3
Addressing geographic variation in dry eye disease care requires patient-centric approaches
4
How screen time and eyelid health affect dry eye risk
5











